Completed Brain & Nervous System Genetics & Molecular Biology

Synaptopathies: genetics, biophysics and circuit mechanisms of paroxysmal neurological disorders.

In plain English

AI plain-English summary

Millions of people with epilepsy, migraine, and other paroxysmal neurological disorders carry genetic variants that disrupt how their neurons communicate, but the specific genes and mechanisms remain unknown for most cases. This research addresses a fundamental gap: while rare, inherited forms of these disorders are linked to genes controlling synaptic transmission—the release and reception of chemical signals between neurons—the genetic basis of common, non-inherited forms is poorly understood. The team will sequence DNA from patients, identify candidate variants, and then test those variants in living cells and animals to see exactly how they alter synaptic function. They will also use the mutations themselves as tools to uncover basic principles of how synapses work. If successful, this work could identify new therapeutic targets for conditions that affect tens of millions of people worldwide. Because these disorders are episodic—symptoms come and go—understanding the underlying synaptic instability might eventually lead to treatments that prevent attacks rather than just manage symptoms. The project is primarily fundamental science, but similar mechanistic studies of synaptic proteins have previously led directly to drugs for epilepsy and migraine.

View original technical description
Several neurological diseases characterised by paroxysmal symptoms, including epilepsy, migraine, ataxias and dyskinesias, exhibit strong heritability, yet the underlying genes and cellular mechanisms are largely unknown. In the rare cases where inheritance is Mendelian, the genes overwhelmingly encode proteins involved in synaptic transmission: ion channels, transporters and components of the neurotransmitter vesicle cycle. Polygenic variability in synaptic proteins is likely to account for the non-Mendelian heritability of common forms of these paroxysmal diseases. A possible explanation for their episodic nature is that homeostatic regulation of neuronal excitability and synapses partly compensates for alterations in the function of individual signalling molecules. Understanding the pathogenesis of these diseases requires a dialogue between clinical genetics and mechanistic studies of the synapse. We will apply deep phenotyping and sequencing to identify candidate genetic variant s in patients with paroxysmal neurological disorders, will harness biophysical insights into vesicle trafficking, ion channel function and synaptic integration to stratify these variants, and will study their consequences by systematic mutagenesis coupled with functional evaluation in vitro and in vivo. Conversely, we will use disease-associated mutations as insights into the mechanisms of synaptic transmission. The programme of research promises both to advance understanding of disease mechanis ms and identify therapeutic targets.

View the original record at the funder ↗

Researchers

Dimitri Kullmann (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Genes to networks - insights into dynamic brain pathology from genetic epilepsies
Activity-dependent regulation of synaptic strength and cellular mechanisms of migraine
Modulation of Basket cell microcircuits in cerebellar cortex paroxysmal ataxia disorders
Synaptic Dysfunction in Neuropsychiatric Disorders
Impairment Of Neural Plasticity And Adaptive Representations By Genetic Risk Factors For Schizophrenia

Original classification

Strategic Award - Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.